BWAY

BrainsWay Ltd.

Price

$13.51

return (12m)

74.66%

p/e

55.46

p/bv

6.65

DIVIDEND YIELD

0.00%

BWAY price

BrainsWay

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BWAY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-9.02%

3 months

-9.27%

1 year

74.66%

2 years

229.91%

5 years

245.97%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BWAY

Valuation

P/E

55.46

Sector 1.09

Industry -1.78

P/BV

6.65

Sector 1.86

Industry 1.35

P/Revenue (PSR)

8.68

Sector 1.55

Industry 2.25

EV/EBITDA

109.37

Sector -47.62

Industry -42.38

EV/EBIT

122.03

Sector -27.52

Industry -45.58

P/EBITDA

38.94

Sector -32.64

Industry -23.10

P/EBIT

44.35

Sector -43.02

Industry -27.18

P/Total Assets

4.32

Sector 0.87

Industry 0.82

P/Net Current Assets

13.64

Sector -27.09

Industry -72.46

P/Working Capital

8.97

Sector -4.05

Industry -2.10

EPS

0.24

Sector -0.70

Industry -1.11

BVPS

2.03

Sector 4.34

Industry 2.54

Efficiency

Gross Margin

75.35%

Sector 49.36%

Industry 50.48%

EBITDA Margin

24.78%

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

22.21%

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

12.46%

Sector -19.73%

Industry -25.75%

Net Profit Margins

15.65%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.14

Sector 0.13

Industry 0.06

Profitability

ROE

12.00%

Sector -24.32%

Industry -33.33%

ROA

7.79%

Sector -24.41%

Industry -45.72%

ROIC

16.92%

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

3.59

Sector 1.90

Industry 2.51

Net Debt / EBITDA

-14.90

Sector -4.96

Industry -8.98

Net Debt / EBIT

-16.62

Sector -3.08

Industry -37.38

Net Debt / Equity

-0.80

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.00

Sector -0.74

Industry -0.56

Equity/Assets

0.65

Sector 0.46

Industry 0.52

Liabilities/Assets

0.35

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

15.40%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals BWAY

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF BrainsWay ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$13.51

Fair Value

$3.31

Upside

-75.49%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BWAY BrainsWay Ltd.	$13.51	68.24%	0.00%	55.46	6.65	12.00%	15.65%
ISRG Intuitive Surgical Inc.	$392.49	-9.49%	0.00%	44.01	7.60	17.26%	28.62%
ABT Abbott Laboratories	$102.63	-21.99%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.33	1.59%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$43.52	-55.82%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$87.47	-27.00%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$227.07	-15.55%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$512.11	-20.09%	0.00%	35.48	25.07	70.67%	25.03%
COHR Coherent Inc.	$308.78	198.60%	0.00%	75.62	5.36	7.09%	11.19%
SYK Stryker Corp.	$276.81	-25.56%	1.26%	28.38	4.41	15.55%	14.43%
PHG Koninklijke Philips NV	$24.65	-8.23%	4.11%	18.19	1.78	9.80%	6.30%
INMD InMode Ltd.	$14.32	-4.12%	0.00%	10.90	1.34	12.32%	20.69%
DXCM DexCom Inc.	$88.64	15.96%	0.00%	33.89	12.92	38.14%	20.12%
BDX Becton Dickinson and Company	$180.03	-1.10%	2.34%	52.21	2.01	3.86%	6.30%
EW Edwards Lifesciences Corp.	$88.26	17.37%	0.00%	50.69	4.74	9.36%	15.41%
ALGN Align Technology Inc.	$147.59	14.02%	0.00%	27.43	2.68	9.77%	9.99%
SNN Smith & Nephew PLC	$27.54	-23.70%	2.80%	19.48	4.52	23.22%	9.83%
IRMD iRadimed Corporation	$82.52	17.96%	1.54%	45.76	10.37	22.66%	26.70%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BWAY Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT BrainsWay

BrainsWay Ltd.

Average Investor10 user rating

4.0 (3 people)

United States

20 years

Founded: 2006

2019

Time since IPO - 7 years

100

Employees

BrainsWay Ltd. (United States) is listed on the Nasdaq and has a market capitalization of $526.89 million, with shareholders equity totaling $79.19 million.

The company employs approximately 100 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, BrainsWay Ltd. reported $60.69 million in revenue, generating net income of $9.50 million.

Key financial metrics include a P/E ratio of 55.46, a price-to-book (P/B) ratio of 6.65, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BWAY.

Market cap

$526.89 million

Net worth

$79.19 million

$79,190,000.00

Assets

$121.97 million

$121,970,000.00

Total Shares Outstanding

39.00 million

39,000,000

Average Daily Trading Volume

$121.43 Thousand

$121,430.30

Sector

Health

Industry

Medical Supplies and Equipment

BWAY

BWAY revenue and profits

Financial Results BWAY

DRAG THE FRAME TO SEE MORE DATA

BWAY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.45 21,79% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.31 --3,58% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.99 107,71% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$384.07 54,21% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.38 --7,54% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,142.35 52,87% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$429.56 7,48% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$139.78 15,92% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35